The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Grifols, S.A(NASDAQ:GRFS) 
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others segments. The Bioscience segment produces plasma-derived medicines for the treatment...
Website: http://www.grifols.com
Founded: 1940
Full Time Employees: 24,000
Sector: Healthcare
Industry: Drug Manufacturers-General
Grifols S.A Days Payable Outstanding ttm (DPO)
Grifols S.A Days Receivable Outstanding ttm (DSO)
Grifols S.A Days Inventory Outstanding ttm (DIO)
Grifols S.A Op Cashflow Per Share ttm
Grifols S.A Free Cashflow Per Share ttm
Grifols S.A Cash Per Share ttm
Grifols S.A P/S ratio ttm
Grifols S.A (GAAP) P/E ratio ttm
Grifols S.A P/B ratio ttm
No extra charts and metrics for this ticker.